Henan Sainote Biotechnology Co., Ltd.

INNOVATION FOR PATHOLOGY DIAGNOSIS

Home News & Event

NordiQC Assessment-HER2 IHC mAb clone C1F7

2020-08-18

By snt_manager

    Share to:

 

 

 

 

 

 

 

 

 

Celnovte Biotechnology HER2 IHC-mAb clone C1F7 has  got Nordic immunohistochemical quality control. The quality of our products are strictly controlled. More assessment details about HER2 IHC-mAb clone C1F7, please see pictures and the website. Welcome to tell us your demands and contact us on email [email protected]

Related News